HIV neuropathy: Insights in the pathology of HIV peripheral nerve disease

Abstract  HIV‐associated neuropathies (HIV‐N) have become the most frequent neurological disorder associated with HIV infection. The most common forms of HIV‐N are the distal sensory polyneuropathy (DSP) and antiretroviral toxic neuropathies (ATN), disorders characterized mostly by sensory symptoms that include spontaneous or evoked pain that follow a subacute or chronic course. The main pathological features that characterize DSP and ATN include “dying back” axonal degeneration of long axons in distal regions, loss of unmyelinated fibers, and variable degree of macrophage infiltration in peripheral nerves and dorsal root ganglia. Marked activation of macrophages as well as the effect of proinflammatory cytokines appear to be the main immunopathogenic factors in DSP. Interference with DNA synthesis and mitochondrial abnormalities produced by nucleoside antiretrovirals have been hypothesized as pathogenic factors involved in ATN. The use of skin biopsy has become a useful tool in the evaluation of HIV‐N. Reduction in fiber density, increased frequency of fiber varicosities and fiber fragmentation are prominent features of skin biopsies from patients with HIV‐N. Other forms of HIV‐N include acute or chronic inflammatory polyneuropathies, uncommon disorders that may ocur during seroconversion or early stages of HIV infection. Opportunisitic infections, mostly associated with cytomegalovirus or herpes zoster virus infection occur in late stages of AIDS and produce characteristic clinical features such as mononeuritis multiple or radiculopathies.

[1]  G. Moyle Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity. , 2000, Clinical therapeutics.

[2]  C. Crumpacker,et al.  Progressive polyradiculopathy in acquired immune deficiency syndrome , 1986, Neurology.

[3]  C P Das,et al.  Neurological complications of HIV infection. , 1998, Neurology India.

[4]  M. Dalakas,et al.  Mitochondrial toxicity of antiviral drugs , 1995, Nature Medicine.

[5]  P. Mezin,et al.  Ultrastructural changes associated with peripheral neuropathy in HIV/AIDS. , 1991, Ultrastructural pathology.

[6]  R. Guiloff,et al.  Nature and incidence of peripheral nerve syndromes in HIV infection. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[7]  J. Glass,et al.  Clinicopathologic correlations of HIV‐1‐associated vacuolar myelopathy , 1994, Neurology.

[8]  F. Goebel,et al.  Neurological manifestations of cytomegalovirus infection in the acquired immunodeficiency syndrome , 1999, International journal of STD & AIDS.

[9]  G. Parry,et al.  Polyradiculoneuropathy, polyradiculitis, and CMV in AIDS and ARC , 1987, Neurology.

[10]  G. Mckhann,et al.  Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. , 1995, Brain : a journal of neurology.

[11]  B. Brew The clinical spectrum and pathogenesis of HIV encephalopathy, myelopathy, and peripheral neuropathy. , 1994, Current opinion in neurology.

[12]  P. Shapshak,et al.  Expression of HIV‐1 and interleukin‐6 in lumbosacral dorsal root ganglia of patients with AIDS , 1994, Neurology.

[13]  F. Authier,et al.  Peripheral neuropathy in human immunodeficiency virus—infected patients with the diffuse infiltrative lymphocytosis syndrome , 1997, Annals of neurology.

[14]  M. Dalakas,et al.  Neuromuscular diseases associated with human immunodeficiency virus infection , 1988, Annals of neurology.

[15]  C. Lacroix,et al.  Inflammatory lesions of peripheral nerve in a patient with human T‐lymphotropic virus type I‐associated myelopathy , 1988, Annals of neurology.

[16]  R. Price Neuropathy complicating diffuse infiltrative lymphocytosis , 1998, The Lancet.

[17]  T. Patterson,et al.  Temporal development of 2',3'-dideoxyinosine (ddI)-induced peripheral myelinopathy. , 2000, Neurotoxicology and teratology.

[18]  P. Shapshak,et al.  Parvalbumin and calbindin D‐28 k immunoreactivity in dorsal root ganglia in acquired immunodeficiency syndrome , 1996, Neuropathology and applied neurobiology.

[19]  D. Simpson,et al.  HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment. , 2000, Drugs.

[20]  J. McArthur,et al.  Intraepidermal nerve fiber density in patients with painful sensory neuropathy , 1997, Neurology.

[21]  L. Montagnier,et al.  ACUTE NEUROPATHY COINCIDENT WITH SEROCONVERSION FOR ANTI-LAV/HTLV-III , 1986, The Lancet.

[22]  P. Shapshak,et al.  Increased NADPH-diaphorase reactivity and cytokine expression in dorsal root ganglia in acquired immunodeficiency syndrome , 1996, Journal of the Neurological Sciences.

[23]  M. Dalakas,et al.  Neuropathies in HIV infection. , 1996, Bailliere's clinical neurology.

[24]  P. Lantos,et al.  HIV‐Associated Disease of the Nervous System: Review of Nomenclature and Proposal for Neuropathology‐Based Terminology , 1991, Brain pathology.

[25]  G. Stoll,et al.  Macrophage responses in inflammatory demyelinating neuropathies , 1990, Annals of neurology.

[26]  C. Wiley,et al.  Spinal cord and peripheral nerve pathology in AIDS: The roles of cytomegalovirus and human immunodeficiency virus , 1989, Annals of neurology.

[27]  C. R. Snyder,et al.  Peripheral neuropathy in a cohort of human immunodeficiency virus-infected patients. Incidence and relationship to other nervous system dysfunction. , 1991, Archives of neurology.

[28]  P. Shapshak,et al.  Morphometric analysis of the peripheral neuropathy of AIDS , 1998, Muscle & nerve.

[29]  H. Vinters,et al.  Abnormalities of peripheral nerve in patients with human immunodeficiency virus infection , 1988, Annals of neurology.

[30]  F. Quismorio,et al.  Polyarteritis nodosa-like vasculitis in human immunodeficiency virus infection. , 1995, The Journal of rheumatology.

[31]  F. Chrétien,et al.  Neuropathy in diffuse infiltrative lymphocytosis syndrome , 1998, Neurology.

[32]  M. Swash,et al.  Bell's palsy and HIV infection. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[33]  R. Guiloff,et al.  Hypothesis on the pathogenesis of vacuolar myelopathy, dementia, and peripheral neuropathy in AIDS , 1998, Journal of neurology, neurosurgery, and psychiatry.

[34]  R. Schooley,et al.  Peripheral neuropathy in the acquired immunodeficiency syndrome , 1988, Annals of neurology.

[35]  D. Simpson,et al.  The pathogenesis of diffuse infiltrative lymphocytosis syndrome , 1998, Neurology.

[36]  M. Tagliati,et al.  Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[37]  C. Lacroix,et al.  Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: A clinical and pathological study , 1991, Annals of neurology.

[38]  C. Fichtenbaum,et al.  Risk factors for dideoxynucleoside-induced toxic neuropathy in patients with the human immunodeficiency virus infection. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[39]  D. Shin,et al.  Spectrum of opportunistic infections and malignancies in patients with human immunodeficiency virus infection in South Korea. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  C. H. Chen,et al.  Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. , 1991, Molecular pharmacology.

[41]  J. Hauw,et al.  The spectrum of polyneuropathies in patients infected with HIV. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[42]  Anne Lohrli Chapman and Hall , 1985 .

[43]  J. Hauw,et al.  The spectrum of changes on 20 nerve biopsies in patients with HIV infection , 1989, Muscle & nerve.

[44]  H. Hollander,et al.  Polyradiculopathy due to cytomegalovirus: report of two cases in which improvement occurred after prolonged therapy and review of the literature. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[45]  G. Rosoklija,et al.  HIV-1 associated sensory neuropathy: a patient with peripheral nerve vasculitis. , 1996, Muscle & nerve.

[46]  J. Piette,et al.  Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. , 2000, Medicine.

[47]  D. Cornblath,et al.  Predominantly sensory neuropathy in patients with AIDS and AIDS‐related complex , 1988, Neurology.

[48]  D. Price,et al.  Gracile tract degeneration in patients with sensory neuropathy and AIDS , 1988, Neurology.

[49]  O. Nascimento,et al.  Distal sensory polyneuropathy in a cohort of HIV-infected children over five years of age. , 2000, Pediatrics.

[50]  D. Katzenstein,et al.  A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection , 2000, Neurology.

[51]  C. Petito,et al.  HIV-1 heterogeneity and cytokines. Neuropathogenesis. , 1995, Advances in experimental medicine and biology.

[52]  J. Griffin,et al.  Inflammatory demyelinating peripheral neuropathies associated with human T‐cell lymphotropic virus type III infection , 1987, Annals of neurology.

[53]  G. Nuovo,et al.  Human immunodeficiency virus infection of dorsal root ganglion neurons detected by polymerase chain reaction in situ hybridization , 1997, Annals of neurology.

[54]  A. Guerrero,et al.  Acute polyradiculopathies in HIV-infected patients , 1997, Journal of Neurology.

[55]  J. McArthur,et al.  Subclinical sensory neuropathy in late-onset restless legs syndrome , 2000, Neurology.

[56]  A. Latif,et al.  Guillain‐Barré syndrome associated with human immunodeficiency virus infection in Zimbabwe , 1991, Neurology.